Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I bought in on December 28, 2017
At $ .0859 ... I feel like I should have sold yesterday when it reached $ .85 ... I'd have had a nice profit. But I held out for the $1.00 and not there yet.
I think the Arnold Sports Fest will brig prices up. But that's 28 days away. Still gonna wait and pray it makes it to my target price of $ 1.00.
Should investors run for the exits or buy the dip?
January 31, 2018 - 5:30 a.m.
Here we go again! After a robust nine-year bull run, the stock market is once more confounding investors. With the Dow Jones industrials, S&P 500 and Nasdaq composite pulling back sharply in Monday and Tuesday trading, warnings of the advent of a significant market meltdown have accelerated.
"Head for -- no, run for the exits" is the urgent advice of the reawakened bears. And a number of market watchers who don't fall under the category of professional bears are expressing concern, too, not only about the uninterrupted ramp-up of stock prices but about what could be a looming political upheaval.
"I sense a Constitutional crisis is imminent with Special Counsel Robert Mueller indicting high-level Trump administration officials," warned George Brooks, editor of the daily market blog, "Investors first read."
"I believe President Trump will respond with an attempt to fire Mueller or find another way to obstruct the progress of the investigation" into allegations of Russia's efforts to influence the presidential election, Brooks argued.
He warned that if that scenario unfolds, initially the market will plunge -- but a rally would likely follow. "As the Constitutional crisis deepens, the market will take a huge hit, with the Dow industrials giving up some 13 percent and the S&P 500 by about 12 percent." The reason for the crisis, said Brooks, "is because the Republicans have ramped up their efforts to discredit the FBI and the Mueller probe."
On the other hand, several veteran market watchers contend that the stock market is actually in a "melt-up" scenario in which stock prices will continue their upswing for some time (in spite of the two-day deep decline).
But this melt-up is "very unusual" because it's earnings-driven, argued Ed Yardeni president and chief investment strategist at Yardeni Research. "Past stock market melt-ups, particularly the ones that occurred during 1929, 1987 and 1999, were P/E or price-earnings-led melt-ups," he noted in his Jan. 29 market appraisal.
"That's why we've been raising the odds of a melt-up recently without raising the odds of a meltdown," he said.
Economic booms tend to be followed by busts "associated with speculative excesses during the booms," noted Yardeni. So the boom-bust cycle is very much tied to the melt-up/melt-down credit cycle, he added. But despite all the commotion during 1987, analysts' consensus earnings estimate for the S&P 500 continued to move higher that year. "There was no recession," Yardeni recalled, "and stocks were deemed to be a bargain."
Yardeni pointed out that a melt-up followed by a melt-down won't necessarily cause a recession. "It might be more like 1987, creating a great buying opportunity, assuming that we raise some cash at the top of the melt-up's ascent," he said.
Before the stock market's two-day sell-off, the S&P 500 index recorded 14 new all-time highs in only 18 trading days, noted Sam Stovall, chief investment strategist at CFRA. In addition, 87 percent of the 145 subindustries in the S&P composite 1500 traded above their 50-day moving average.
Moreover, the S&P 500 had advanced 34 percent in price since getting back to break-even from the May 2015-February 2016 sell-off, noted Stovall, "versus the average post-correction climb of 9.5 recent before slipping into a new decline of 5 percent or more."
In all, the latest pullback in equities creates a long-awaited opportunity for the many investors who want to participate or even just to add to their favored stocks. So even though this may be the long-awaited correction -- and may really pound stock prices a lot lower than anticipated -- history implies that investor worries might be unfounded in the near term, said Stovall, and that the market still has further to run.
Indeed, several analysts believe the bull market is far from dead in spite of the recent turmoil.
Some savvy stock pickers suggest that the market dive has stocks that appeared unattainable as their prices continued to climb now looking like opportunistic buys, including Amazon (AMZN), Apple (AAPL), Facebook (FB), CVS Health (CVS) and Microsoft (MSFT).
One stock added to that list yesterday was McDonald's (MCD), as CFRA raised its earnings forecasts for 2018. Tuna Amobi, equity analyst at CFRA, boosted his 2018 earnings estimate by 14 cents a share, to $7.16, and maintained his "buy" rating on the stock, with a price target of $195 a share.
With the stock currently trading at $176, noted Amobi, "McDonald's seems well on track with its financial targets pursuant to its "Velocity Growth Plan."
https://www.cbsnews.com/news/should-investors-run-for-the-exits-or-buy-the-dip/
www.otcmarkets.com
Check OTC board and you'll see the difference.
They are not the same company.
The "Q" means that company has filed bankruptcy.
The "Q" is added when they file.
They haven't worked their way out of it yet
and it has been a year that I've been watching it.
I love your terminology/sarcasm ...
You keep me laughing at this stock !!!!
AND looking at reality at the same time!
GAWD YOU'RE GOOD!
Another ... might be good ... not sure yet
Atacama Resources International, Inc. ^ 185%
I've located another "pot stock" that I feel will be as great as this one is .... Premier Biomedical Inc.
Negative Side Effects of Cannabis
https://vapingdaily.com/marijuana-side-effects/
Like any other drug (including alcohol), the side effects from marijuana vary from person to person. One person might feel stressed and even disoriented while other might feel relaxed and focused. In addition to your body, several other factors including type and amount of cannabis, your mood or the current state of mind, your circumstances, environment/settings, your diet, and many others, can also play a huge rule in determining the effects of weed you’ll experience.
The most common and obvious side effects of THC are bloodshot eyes and dry mouth. And that’s why you’ll see that most potheads carry some sort of eye washing product with them. Other commonly reported side effects include, but not limited to, pointless giggling, sloth-like reflexes, loss of inhibitions, an enhanced appreciation for things like colors, music etc. you wouldn’t pay much attention to normally.
Most types of cannabis are mild, however, strong cannabis (e.g. skunk or purple haze) or too much usage can have stronger effects such as hallucination while some people also report increased anxiety and paranoia. Although it doesn’t augment risk-taking behavior like alcohol does, weed does impair mental functions such as memory, attention, and performance, which makes driving or operating heavy machinery risky.
Health Risks of Cannabis
Marijuana-health-risks
While many believe marijuana to be extremely dangerous, it’s actually considerably less harmful than other substances in the same class such as barbiturates, amphetamines etc. In fact, occasional use of weed is hardly ever associated with any health issues. Even for serious users, science has yet to prove any solid evidence of major health problems for the users or the society. Especially in individuals who are otherwise healthy, the biggest real harm marijuana can do is impaired control of movements.
However, for people who have heart and circulation disorders, low blood pressure, diabetes, or schizophrenia, weed can pose significant threats. No matter how weed enters your body, it impacts pretty much every major organ in your body in one way or another, though not always negatively. Smoking and vaporizing yield instantaneous high as THC is absorbed immediately by your body, and you can be under the influence for up to four hours. For those who eat pot-laced brownies or cookies, the effects appear after quite. Here are a few issues that weed is commonly believed to trigger or augment.
Dependence
The biggest health issue of weed is dependence. Regular heavy usage might make you dependent, however, it’s far less addictive than tobacco as well as alcohol. In fact, it’s reported that only 10% people who use weed become addicted to it.
Higher Chances of Cardiac Arrest
When smoked, marijuana can increase your heart rate up to two times from the normal rate. The increased heartbeat rate is often linked to increased chances of heart attack, and that’s why doctors recommend heart patients to stay away from any form of cannabis.
Lung Irritation
Modern scientific studies confirm that unlike tobacco cigarettes, smoking cannabis isn’t linked to higher chances of getting lung cancer. But it can cause a cough and chest colds, and extended heavy use is also associate with lung irritation.
Brain Issues
Some people believe they achieve better concentration and mental stability after smoking weed, but THC in cannabis can have both short-term and long-term effects on the human brain.
When THC is absorbed by the body into the bloodstream, all the chemicals are carried to brain in addition to other organs. When THC reaches the brain, it’s supposed to impact certain brain cell receptors that contain chemicals similar to THC itself. These THC-like chemicals control brain development and other functions.
As for short-term effects of weed on the brain, it over-activates the receptor cells and the person feels the “high” and gets into a relaxed mood. The person’s senses of seeing colors or listening and even sense of time are altered. Heavy use can reduce thinking capabilities and can even cause memory loss for the short term.
As for long-term effects, the overall brain development of heavy weed users is believed to be affected, especially if they started using weed in teenage. A study suggested that teenage marijuana smokers lost on average eight IQ points between ages 13 and 38, and most of them never fully recovered even after quitting weed. On the flip side, those who started smoking weed in adult age didn’t lose any IQ points.
Impact on Sexual Health and Reproduction
For men, frequent heavy use of marijuana can affect sexual health by lowering their testosterone levels and sperm count, which could result in reduced fertility. Likewise, pregnant women, as well as babies in their womb, can be affected by marijuana use. For instance, because of the high levels of carbon monoxide in the smoke, birth weight could be lower than normal of the children whose mother has been smoking weed during pregnancy.
Other Health Risks of Cannabis
Some other common physical effects of weed are short-term forgetfulness, depression, dizziness, increased appetite, and slowed down reflexes. Heavy users who have been using weed for long periods of time can experience withdrawal symptoms when they stop taking the drug.
Increasing Levels of THC
Marijuana has been in use for centuries, however, in the past few years, the THC levels in cannabis are believed to be going up. Cannabis used to contain a maximum of 4% THC, but now this has gone as high as 7%. The increased levels of THC worries many health professionals who believe that now it might become more addictive and more potent for producing mind-altering impacts. It’s very hard to know the exact level of THC or other chemicals in cannabis, so even if you’re buying from a regulated dispensary, it’s difficult to have an idea how much THC your body will absorb and thus knowing the exact effects can be difficult. But many health professionals claim that increasing levels of THC can increase the potential side effects of marijuana use.
Can we Minimize the Side Effects of Weed?
Is marijuana lethal? Maybe not. Is it very dangerous? Science has yet to figure out whether its cons outweigh its pros or not. Is it more dangerous than tobacco? No. According to American Lungs Association, marijuana has four times more tar than tobacco, but the largest study of its kind shows it’s not linked to lung cancer, even in a case of heavy, regular smokers.
But at the end of the day, there are some side effects of marijuana. Tar, as well as other carcinogens, are released when weed or tobacco undergo combustion. So, people use alternative methods such as eating or drinking weed with food. But these methods have their downsides; for instance, making pot-laced brownies or brewing tea that has weed, is a lengthy and complicated process.
This leaves us with the modern, high-tech method of vaporizing weed. In this method, a modern device called vaporizer is used to turn weed into vapors by bringing it into contact with a heating element. Since there is no combustion, there is no tar and many other compounds that make weed harmful. Studies show that e-cigarettes are at least 95% less harmful than tobacco, and the same goes for weed. The good thing is that new vaporizers are refining the technology to further minimize or eliminate the risks involved, and the prices are also coming down. But don’t forget that there are a couple of hassles, like setting up the device and clean up the process, attached to vaping weed, which can be off-putting for someone who is used to instantly rolling and smoking a joint.
Remember, knowing the potential weed side effects and how to minimize them can go a long way for a healthy living, no matter you use marijuana for medical purposes or just for medical reasons.
My personal opinion combined from my own research and from watching family members waste their lives smoking marijuana, I thin it's extremely harmful to the individuals and to our society. It will eventually have long term effects of our health care system, our care givers, our welfare system and our tax dollars.
CBD oil which is being legalized all over the USA has very little THC and far less risks and far more benefits.
Laying around giggling and eating all day isn't productive to our society or to our individual selves. Anxiety, paranoia, depression equally bad for all.
McDonald’s of Dispensaries; Sun Maid Raisins of Growers; Splenda of Extracts ... a quote from December 19, 2017
5 Name Changes in 17-18 years
4 decrease splits
8 months ago 1-20,000
NO Investor Relations Firm listed
McDonald’s of Dispensaries;
Sun Maid Raisins of Growers;
Splenda of Extracts
In order to become all they want to become they need an excellent Investor Relations Firm on board typing out press releases that get folks interested.
We've not been seeing any of that.
I'd LOVE to see USMJ get up and running but I've seen NOTHING but down turns since the last split in May 2017.
Management need to get up n get to gettin'.
I Emailed Hemp, Inc last night ...
Got the following reply at 9:57 A.M. Central Time.
Hi XXXXXXXX,
I represent Hemp, Inc.
Hemp, Inc. appears to be “defunct” because OTC says we are not current with our financials.
If you go to our website you will see that we are current with all financials and we are working closely with OTC to get the issue resolved.
http://hempinc.com/financial-disclosures/
Steffan Dalsgaard, President
Everest Corporate Advisors, Inc.
Office Phone: 702-902-2361
Direct Phone: 415-250-0105
I most certainly hope you are correct! BUT ... in reality this is a huge hit for Abattis and it could take a good long while to bounce back from it. Meanwhile .... the stock holders are the ones sitting and waiting for recovery of their investments. That's never a good thing. Stock holders lose faith in the company.
The accusations made against Abenante ... I doubt that BLXX would make unfounded accusations against Mr. Abenante. They'd fear a deformation/slander etc suit against them. The case hasn't been settled yet ... at least I find nothing about settlement. It may have been settled privately who knows for sure. In any case ... BLXX feels justified in filing this suit ... time will tell.
Yes ... all the 'pot stocks' took a huge hit when Sessions spouted off ... Sessions has his reasons for spouting off and in part I do understand his concerns but only after I did my own research on the side effects of 'smoking pot' which is what Sessions said ... 'good people do not smoke pot'. Veterans smoked pot, nurses, doctors, judges, lawyers even law enforcement officers have smoked pot and for the most part it was done to calm nightmares. The side effects are not good for individuals and they will not be good for this nation as a whole. I think Sessions is more concerned about the legalization of recreational pot smoking and NOT medical marijuana ... but I could be wrong. I'm certainly NOT defending Sessions ... He should have spoken differently and NOT lumped all under one umbrella.
I've come to realize that not all marijuana is created equal. AND that HEMP is different as well. Each plant has it's own unique properties ... health benefits and risks. BUT ... without the THC those unique properties are of great benefit to humans and even to animals. The THC causes dependence/addiction and a variety of other bad side effects.
If we are not careful ... this could become the next addiction in the USA similar to alcohol and prescription drugs.
We all need to think more about what we are putting into our bodies. We only get ONE BODY in this life time and we should take better care of it.
I did read back several pages and I did not locate the article I posted ... that's why I posted it. I wasn't attempting to repeat old news or take over this board.
Loophole in the law ...
I think this guy is using people and their circumstances for his own personal financial gains.
Reservation Law is different than County, State or Federal law.
Personally ... I think this tribe has been duped into this at their expense and he's riding their lawsuit, using their misfortune, which he created, to his personal advantage. Everyone is entitled to their opinion and this is mine. Opinions change with new findings.
The pictures I've seen show huge Hemp plants with no fencing around the property. IF this crop was illegal, how did they obtain the seed/plants? How did the plants get so big before the local law chose to burn it? Burning it renders the land useless for quite a while. Which means the Tribe can't plant anything else there and grow it for profit. Bad deal for sure.
ATTBF - Robert Abenante - CEO, President being sued
https://www.pressreader.com/canada/stockwatch-daily/20170911/281505046375272
Blox sues former President Abenante September 11, 2017
The suit claims Abenante made unsubstantiated payments with company money and failed as Presindet of Blox (BLXX)
I think this may be why ATTBF isn't doing very well.
Hemp is not the same as 'POT'
Hemp is referred to around here where I live as Ditch Weed or loco weed and farmers/ranchers don't want it in their field because they don't want cattle grazing on it because they go loco. They don't want it processed into in hay. Many states have banned growing it.
There's less than .03% THC in Hemp and it's grown for industrial uses. The oil from Hemp is used in cosmetics. The only thing you'll get from smoking Hemp is a boomer headache akin to a migraine. But when dried it's difficult for the inexperienced to tell the difference between Hemp and various strains of marijuana.
The following article explains the difference in Marijuana and Hemp and the helpful uses of Hemp.
https://www.medicaljane.com/2015/01/14/the-differences-between-hemp-and-cannabis/
What Is Hemp? Understanding The Differences Between Hemp and Cannabis
Raymond C. Dabney/Cannabis Science, Inc / CBIS did not own that field of Hemp ... the Indian tribe owned it. It was on reservation land BUT STILL illegal to grow it. Mr. Dabney manipulated the tribe and it's chief into growing the illegal Hemp crop.
Raymond Christopher Dabney, a majority shareholder,
[url]
https://www.bcsc.bc.ca/News/News_Releases/2005/62_Advertising_firm_head_admits_to_misrepresentations/[/url][tag]insert-text-here[/tag]
Advertising firm head admits to misrepresentations
2005/62
November 21, 2005
Vancouver – A Vancouver-based advertising company and its principal have admitted to publicly misrepresenting the company’s financial information and business transactions in a settlement reached with the British Columbia Securities Commission.
Raymond Christopher Dabney, a majority shareholder, and formerly the president, chief executive officer and a director, of XRAYMEDIA, Inc., is banned for at least five years from being a director or officer of any issuer, trading in any securities and from engaging in any investor relations activities. He must also pay the BCSC $30,000 as part of the settlement.
Dabney, a B.C. resident, directed the operations of XRAYMEDIA, a Minnesota, U.S.-incorporated firm that trades its securities on the National Association of Securities Dealers Over the Counter Bulletin Board. The company’s employees, operations and computer servers are located in Vancouver. XRAYMEDIA purports to be a traditional, full-service advertising agency that hosts an internet-based marketplace for buying and selling advertising that it lists as “media inventory.”
In the settlement, Dabney admitted that between March and September 2003, on behalf of XRAYMEDIA, he issued 22 news releases that contained misrepresentations about the company’s revenue, commissions earned and the inventory being sold through its internet-based marketplace.
Dabney also admitted that on July 23, 2003, he issued a news release on behalf of XRAYMEDIA that said that the company’s shares would yield a profit of $0.02 a share, contrary to section 50(1)(b) of the Securities Act.
The B.C. Securities Commission is the independent provincial government agency responsible for regulating trading in securities within the province. You may view the settlement on our website www.bcsc.bc.ca by typing in the search box, XRAYMEDIA, Inc., Raymond Christopher Dabney or 2005 BCSECCOM 673. If you have questions, contact Andrew Poon, Media Relations, 604-899-6880.
Raymond Christopher Dabney- Canadian Court Rules
https://www.bcsc.bc.ca/Enforcement/Disciplined_Persons_List/Dabney,_Raymond_Christopher/
Dabney, Raymond Christopher
Date of Order or Settlement:
2005-11-15
Banned Until:
2010-11-15
Sanction:
5-year trading ban with conditions
5-year director/officer ban with conditions
5-year investor relations ban with conditions
An order to comply fully with the Securities Act, the Securities Rules, BC Reg. 194/97, and any applicable regulations, policies and guidelines
Supporting Documents:
News Release
Settlement/Order New window
Violation:
Misrepresentations
Prohibited representation
Ruling Body:
BCSC
Payment Agreed/Ordered:
$30,000
Almost 11 years and still at it!
https://www.sec.gov/news/digest/2008/dig081108.htm
August 8, 2007
SEC Charges Participants in Fraudulent Scheme to Manipulate Stock and Evade Registration Requirements and Settles Charges Against Attorney
On August 8, the Commission charged Alliance Transcription Services, Inc. and others in connection with a scheme to manipulate Alliance's stock price and trading volume through false and misleading public disclosures and to issue and sell Alliance's common stock in an unregistered distribution. Alliance is a Nevada corporation, formerly known as Strategy X, Inc., that was headquartered in the State of Maine from at least December 2004 through August 2007, and is now located in Ranch Palos Verdes, California. Also charged for various roles in the scheme were Clifford A. Lewis of Huntsville, Alabama; Richard A. Dabney of Rancho Palos Verdes, California; Raymond C. Dabney of Vancouver, British Columbia; Philip M. Young of Phoenix, Arizona; Charles J. Smith of Reno, Nevada; and William D. O'Neal of Fountain Hills, Arizona. The Commission settled charges against O'Neal, an attorney who allegedly issued a series of legal opinions that enabled Alliance to illegally issue purportedly unrestricted shares of its stock in unregistered transactions. O'Neal agreed to pay more than $220,000 in disgorgement of ill-gotten gains, prejudgment interest and civil penalties, and to be prohibited from issuing similar legal opinions in the future or accepting securities of Pink Sheets issuers in consideration for legal services.
According to the Commission's complaint, filed in the United States District Court for the District of Arizona, Alliance, Richard Dabney, and Lewis manipulated the market for Alliance's stock by issuing press releases that made false and misleading claims about the company's contracts and revenues. The complaint alleges that the press releases issued by Alliance were published through business newswire services and on Alliance's website from at least April 2005 through at least September 2006.
The Commission's complaint further alleges that, from July 2005 to September 2006, Alliance, Richard Dabney, Raymond Dabney, Young, Smith, and O'Neal participated in an unregistered distribution of Alliance securities through a series of purported stock offerings by Alliance to North American Funding, Inc. (NAF), a Texas corporation controlled by Smith. According to the complaint, Raymond Dabney, Young, and Smith arranged for Alliance to issue stock to NAF in offerings that purportedly were exempt from registration. The complaint alleges that, in fact, the transactions between Alliance and NAF were not exempt from registration and were merely a device to evade the registration provisions of the federal securities laws. According to the Commission's complaint, the stock was immediately distributed to third parties and sold into the market, without being paid for by NAF. Richard Dabney, an officer and director of Alliance, and O'Neal enabled Alliance to engage in those transactions by providing the necessary corporate resolutions and legal opinions, respectively. The Commission's complaint also alleges that Young, Smith, and O'Neal received some of the Alliance stock through the unregistered distribution and sold it into the market without registration or a valid exemption from registration. According to the complaint, Lewis, Richard Dabney, and Raymond Dabney received a portion of the proceeds that Young obtained by selling the Alliance stock.
The Commission's complaint charges Alliance, Lewis, and Richard Dabney with violating the antifraud provisions of the federal securities laws (Section 10(b) of the Securities Exchange Act of 1934 (Exchange Act) and Rule 10b-5 thereunder) and charges Alliance, Richard Dabney, Raymond Dabney, Young, Smith, and O'Neal with violating the securities registration provisions of the federal securities laws (Section 5 of the Securities Act of 1933 (Securities Act)). In its complaint, the Commission seeks permanent injunctions against all the defendants, disgorgement plus prejudgment interest and civil monetary penalties against Lewis, Richard Dabney, Raymond Dabney, Young, Smith, and O'Neal, officer and director bars against Lewis and Richard Dabney, and penny stock bars against Lewis, Richard Dabney, Raymond Dabney, Young, and Smith.
The Commission previously issued an Order on Oct. 4, 2007, suspending trading in the securities of Alliance.
Upon the filing of the Commission's complaint, and without admitting or denying the allegations in the complaint, O'Neal consented to the entry of a final judgment permanently enjoining him from violating Section 5 of the Securities Act, ordering him to pay disgorgement of $163,246.22 and prejudgment interest of $33,000.78 plus a civil penalty of $25,000. In addition, the final judgment prohibits O'Neal from issuing any legal opinions to the effect that unregistered offerings are exempt from SEC registration under Rule 504 of Regulation D under the Securities Act and that securities issued in such Rule 504 offerings are unrestricted. The final judgment also prohibits O'Neal from accepting securities of any Pink Sheets issuer in consideration for legal or consulting services rendered. [SEC v. Alliance Transcription Services, Inc., Clifford A. Lewis, Richard A. Dabney, Raymond C. Dabney, Philip M. Young, Charles J. Smith, and William D. O'Neal, 2:08-CV-01464-NVW (District of Arizona))] (LR-20676)
Raymond C. Dabney University Website
http://rcdu.com/index.php/contact-us
Raymond C. Dabney
Chairman of the Board
e | raymond@rcdu.com
c | 888-263-0923
2700 West Coast Hwy, 215
Newport Beach, CA 92663
www.rcdu.com
A 2015 article on the Dabney University
https://insiderfinancial.com/cannabis-science-inc-otcmktscbis-continues-to-disappoint
2017 they still haven't built it and two people are dead.
Two Bodies Found-Near Illegal Hemp Field
http://www.recordnet.com/news/20171004/bodies-of-17-year-old-man-were-found-in-pot-grow-officials-say
Raymond C. Dabney - CEO of a University in California
http://www.recordnet.com/news/20171030/hemp-farmers-sue-san-joaquin-county-claim-plants-for-research--were-illegally-removed
October 2017
Raymond C. Dabney is CEO of a University in California that NO ONE can find AND President of Cannabis Science, Inc. Encouraging the planting of unlicensed hemp on reservation lands. A 17 year old boy was found dead near this illegal Hemp field.
https://www.sec.gov/litigation/complaints/2008/comp20676.pdf
August 8, 2008
The 17 page court document on Case 2:08-cv-01464-NVW Filed 08/08/2008
I've contacted the BCSC (British Columbia Securities Commission for information on the 2005 Raymond C. Dabney case. If they respond, I'll post their response on this site.
https://www.bcsc.bc.ca/About_Us/Contact_Us/
I KNOW i't s LongShot, Louie, BUT perhaps you should read my other posts. I did in fact list court case numbers and the correct links to get to the court case documents.
The link YOU so kindly provided ME has RAYMOND C. DABNEY court case listed directly under the case YOU accuse ME of pointing folks to.
I read through all the pages of the court case (17/18 pages) and the scheme he and his brother and others (one man was 84 years old and involved in the scheme) is almost identical to this one.
Again ... TWO judges in TWO COUNTRIES have court documents posted ONLINE stating Raymond C. Dabney is a STOCK MANIPULATOR.
MANIPULATORS do not change, they merely continue to perfect their scheme/s. They are predators and continue to prey ... not PRAY.
Call n ask ... easy way to find out. Let me know.
All that you've said here should be reported to the SEC and can be done online or via fax. Reporting your findings and suppositions will get an investigation going and maybe this time Raymond C. Dabney will go to prison where he belongs.
That's some good Due Diligence! AND so proud of you for sharing your findings in the hopes of helping others.
Dispensaries are applied for, licensed and approved by the state.
Shall we check with the state of California where the business office is located or perhaps Colorado where the sole owner who was recently registered with the SEC.gov listed his address. NO ... Dabney IS NOT the owner of this company as of January 8th, 2018.
look it up ... www.sec,gov then do a search for this company AND do a search for Dabney. You'll be shocked I'm sure.
Some say Dabney deserves a 'second chance' ... The predator, the manipulator, Raymond C. Dabney just LOVES folks like that because THEY are his next victims. A federal judge in TWO COUNTRIES has stated in court that Dabney is guilty of STOCK MANIPULATION.
As I've said before it is much easier to fool someone than it is to convince them they have been fooled.
A reputable CEO would not just say 'we have dispensaries, we have pharmacies, we have government approval,' ... they'd utilize every opportunity to SHOW the public EXACTLY WHERE these businesses are located ... WHY? Because THE PUBLIC is their next customer. Dabney IS NOT doing that.
Leopards do not change their spots, predators are always seeking prey. They hone their skills at every opportunity. When a manipulator doesn't get their way ... it can turn ugly quick.
'It's Easier to Fool People
Than to Convince Them That They Have BEEN FOOLED
You obviously don't get the point.
Raymond C. Dabney is running the same scam AGAIN!
You just can't or won't see it.
Defense Contracts in press releases back then and again now.
2008 is just 10 years ago. He made a butt load of money above and beyond the fines and has been living high and mighty on it.
You think he's turned over a 'new leaf' and learned from his mistakes? He's just perfecting his scheme/scam. He's a manipulator. He's always going to BE a manipulator.
More SEC.gov information for ya
For further information, please see Litigation Release Numbers 20791 (Oct. 24, 2008) [default judgment against Alliance]; 20676 (Aug. 8, 2008) [civil injunctive action filed and judgment by consent against William D. O'Neal]; and 19870 (Oct. 16, 2006) [subpoena enforcement action filed]; and Exchange Act Release Number 56610 (Oct. 4, 2007) [order suspending trading in Alliance securities]. [SEC v. Alliance Transcription Services, Inc., et al., CV-08-01464-PHX-NVW (District of Arizona] (LR-21349)
https://www.sec.gov/news/digest/2009/dig122309.htm
Case 2:08-cv-01464-NVW
It's real easy to locate this information
www.sec.gov
I typed Raymon C. Dabney into the search box.
I'm not gonna stick my head in the sand and let Dabney or anyone else get my hard earned money.
https://www.sec.gov/litigation/complaints/2008/comp20676.pdf
Deena R. Bernstein
United States Securities and Exchange Commission
Boston Regional Office
33 Arch Street, 23rd Floor
Boston MA 02110
GA Bar 054068
(617) 573-4590 (fax)
bernsteind@sec.gov
(617) 573-8813 (office)
Attorney for the United States
Securities and Exchange Commission
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF ARIZONA
___________________
________________
Securities and Exchange Commission,
Plaintiff,
vs.
Alliance Transcription Services, Inc.;
Clifford A. Lewis; Richard A. Dabney;
Raymond C. Dabney;
Philip M. Young; Charles J. Smith; and
William D. O’Neal,
Defendants.
JURY TRIAL DEMANDED
rhoyt ... Article for you
https://www.forbes.com/sites/nathanvardi/2014/03/10/the-first-pot-stock-billionaire-says-his-penny-stock-could-be-a-little-high/#6a07a5ce14bd
Dabney's Linkedin profile makes NO MENTION of ever being with the Minnesota company mentioned in this article.
March 10, 2014
The Financial Industry Regulatory Authority warned investors back in August about marijuana stock scams, saying “the con artists behind marijuana stock scams may try to entice investors with optimistic and potentially false and misleading information that in turn creates unwarranted demand for shares of small, thinly traded companies that often have little or no history of financial success.” It’s not hard to figure out that some of the people behind the penny pot stock boom have questionable backgrounds.
Take Raymond Dabney. In 2005, the British Columbia Securities Commission up in Canada slapped a five-year trading ban on Dabney and barred him from being an officer or director of a publicly-traded company for five years after Dabney admitted to issuing 22 bogus news releases that contained misrepresentations about the revenue of Xraymedia, a Minnesota company in which Dabney was a controlling shareholder. The Securities & Exchange Commission also sued Dabney and in 2010 obtained a final judgment against him that included a disgorgement and penalty of about $190,000. The SEC launched the enforcement action against Dabney and three others in connection with a scheme to manipulate the price and trading volume of Alliance Transcription Services. Today, Dabney works as a management consultant for Cannabis Science, a cannabis formulation-based drug development company that trades on the OTCBB. Dabney is described in SEC filings as the trustee of the Bogat Family Trust, which owned 6.5% of Cannabis Science last year.
Bruce Perlowin, CEO of another Las Vegas-based OTCBB stock called Hemp Inc., is completely open about the nine years he spent in prison for drug smuggling, which he describes on his own web site. “This is a dot.com explosion except there is a real product behind us, not air,” Perlowin recently said in an interview he scored on Bloomberg Television. The Southern Investigative Reporting Foundation last fall exposed the background of Vincent Mehdizadeh, the founder of a marijuana stock called Medbox, which included arrests or no contest pleas for things like trespassing and credit card fraud.
A year ago, an anonymous poster on Seeking Alpha exposed that Michael Llamas, the former president of publicly-traded Medical Marijuana, had been indicted by federal prosecutors in California for his alleged involvement in a mortgage fraud that caused $10 million in losses. Llamas has pleaded not guilty to the federal charges and Medical Marijuana separately disclosed last year that it was being investigated by the SEC.
So there are some shady characters behind the penny pot stock boom. Mackay, who says he has in the past represented other companies with OTCBB stock listings, says CannaVest CEO Michael Mona, Jr., partially brought him aboard to help navigate the OTCBB underbelly. “I am familiar with a lot of the garbage that goes on with over the counter stocks, the pitfalls, and I guess that is one of the reasons why I decided to help Mike and help this process to avoid some of the pitfalls,” Mackay said.
Nevertheless, the indicted Llamas is connected to Mona, Mackay and CannaVest. Mackay’s path to obtaining most of his $1.8 billion of shares in CannaVest starts with Roen Ventures, a company that last year agreed to lend $6 million to CannaVest. Roen Ventures was formed by Mona and Llamas, according to a lawsuit filed against Mona and Mackay in Nevada state court. The lawsuit, filed in February by Far West Industries, claims that Far West obtained a $17.7 million judgment in 2012 against Mona and others relating to a fraudulent land transaction in California. According to the second amended complaint, Mona testified in the judgment debtor exam that he received $3 million that he loaned to Roen Ventures, which lent the money to CannaVest. Mona then testified that in the last year he sold his interest in Roen Ventures and its $3 million note to Mackay for $500,000—making Mackay and Llamas the owners of Roen Ventures, the second amended complaint says. Mona testified that there is another $22 million judgment pending against him connected to another real estate deal, the second amended complaint says. Far West claims in its second amended complaint that Mona’s loan to Roen Ventures was fraudulent and “intended to prejudice creditors like Far West by concealing and wasting assets.” Mackay declined to comment on the lawsuit, except to say that “from my perspective, it’s frivolous and doesn’t hold water.” Mona did not return a call seeking comment for this article.
In January of 2014, CannaVest said in an SEC filing that Roen Ventures is now wholly owned by Mackay, who acknowledged in an interview that he has bought out the stakes of Llamas and Mona in Roen Ventures. According to the January SEC filing, Mackay, through Mercia Holdings and Mai Dun Limited, now owns 100% of Roen Ventures, which has converted its loans to CannaVest to 10 million shares of CannaVest stock.
How did Mackey get the rest of his shares in CannaVest? In November of 2012, two of Mackay’s companies started acquiring shares of a publicly-traded OTCBB company called Foreclosure Solutions, mostly from H.J. Cole. The man behind the deal was Stuart Titus, who loaned the Mackay companies the money and whose General Hemp also participated, taking a 7.1% stake. Foreclosure Solutions became CannaVest and last week for some reason CannaVest moved to distance itself from Titus, saying in a press release that Titus no longer has any affiliation with CannaVest and owns less than 2% of the company.
There is another connection between CannaVest and Llamas. On the last day of 2012, CannaVest agreed to buy assets from something called PhytoSphere, including a license to use its brands, for $35 million in five payments of either cash or stock. When the deal closed last year, CannaVest issued 900,000 shares to PhytoSphere, which distributed the shares to its sole owners, Medical Marijuana and Hemp Deposit and Distribution Corporation, according to an SEC filing. Llamas used to be president of Medical Marijauna and its financial statements have previously describes Llamas as the president of Hemp Deposit and Distribution Corporation. Llamas’ LinkedIn page says he is the founder of Hemp Deposit’s CannaBank business. “To draw an inference that Mike Llamas has something to do with CannaVest is absolutely wrong,” says Mackay. “Llamas is not a member of the board and has absolutely no influence. I know Michael Llamas and am familiar with him but he has no control on any aspect of CannaVest. He may be a shareholder of CannaVest.”
CannaVest’s most up-to-date books show $10.7 million of assets. For the nine months ending September 30, 2013, the last time period for which CannaVest reported financials, revenues were $1.35 million and losses were $28.4 million. Mackay concedes these fundamentals don’t really support a sky-high stock valuation. “What you have here is in some ways, in my mind, is a perfect storm where for some reason marijuana stocks are getting some probably under normal reasonable terms outlandish valuations. I can’t control that because we don’t put out a lot of news, we are not out pumping stock,” says Mackay. “I am focusing on CannaVest and the fundamentals of this business as a member of a board of directors rather than pumping stock in a stock play.”
Do you believe that a company Raymond C. Dabney is CEO of, and a tried and convicted, suspended and fined international stock scammer, and master manipulator will BE AWARDED a US Government contract? I don't.
MORE HOGWASH -
Yesterday Raymond C. Dabney stated CBIS HAD the contracts and today ... they are 'actively pursuing' those contracts.
Cannabis Science Actively Pursuing U.S. Federal Government Contracts and Is Preparing Applications for Submission While Confirming the CBIS Security Team (CBISST) is Ready for Action
IRVINE, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has been actively pursuing contracts under its registration of SAM with three North American Industry Classification System (NAICS) Codes: 541711 – Research and Development in Biotechnology 621511 – Medical Laboratories 624230 – Emergency and Other Relief Services.
Cannabis Science has located and is preparing applications for submission under two of the above three codes and expects these applications to be submitted very soon. Having this information immediately available also allows the U.S. Government to rapidly find the companies with the right capabilities to offer services for required government contracts, government initiatives, including research & development projects, supply needs, up to a pandemic alert requirement or other emergency requirements.
“There is a certain level of clearance Cannabis Science has received from the Defense Logistics Agency’s CAGE Program Office at the U.S. Department of Defense for the Federal Commercial and Government Entity (CAGE) Code program that allows CBIS instant access to U.S. Federal Government contract procurement and that puts the Company directly in line to benefit from the cannabinoid-based medicines industry,” stated Cannabis Science Inc., President & CEO, Co- Founder, Mr. Raymond C. Dabney.
“As for the U.S. Federal Government, we believe we have a significant role to play, as a private sector stakeholder, as well as a company that can support federally-funded contracts and grant opportunities as an experienced contractor. It is our goal to provide patients safe access to the pharmacies and to the drugs they want to heal their critical ailments, also that their personal information is secure.
“This currently is a volatile industry and we clearly see a need to filter out bad influences and bad information there to deceive and confuse the masses. We are educating, building pharmacies, laboratories, and medical centers; patient data protection is of the highest security priority.
“The Cannabis Science security team is here to secure and protect CBIS and all of its proprietary information, operational components, its assets, its people, and most important its valuable public and private patient information. We have experts on the security team that are required for certain situations in support of the worldwide federally funded contracts we are applying for and our current nationwide operations and growth. I am constantly and consistently being updated by assessments the security team is providing that consist of internal and external assessments, then actions are and will be taken accordingly,” stated Cannabis Science Inc., President & CEO, Co- Founder, Mr. Raymond C. Dabney.
The CBIS Security Team (CBISST)
The Cannabis Science Security Team has 30 plus years’ experience in government, private, personal and public security and consists of members from the LAPD, LA Sheriff’s Department, SWAT, Peace Officers, California Guard Card holders armed and unarmed, US Intelligence community, State of Colorado Certified Private Investigators, also the original Nuclear Security Assessment team member used by the United States Air Force.
CBISST team members have experience in global intelligence and have conducted performance based security assessments on all the Air Force's highest priority resources including nuclear weapon storage facilities, the US nation’s highest resources, as well as specializing in risk mitigation, banking, payment processing, executive, asset, and cash movement.
Cannabis Science Security Department is also planning for expansion. While the Newport Beach, California office will expand personnel and capabilities, we are projecting an expansion in the number of contracts, employees and consultants. Our current plan is to add a 4-person Network Security & Vulnerability Branch. CBISST believes that these new capabilities, as well as our continued return customer business base, will again provide us with unique opportunities in both the civilian and government contracting markets.
About Cannabis Science, Inc.
Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Informationconcerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Contact Information
Cannabis Science, Inc.
Dr. Allen Herman
Chief Medical Officer
allen.herman@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
© 2018 GlobeNewswire, Inc.
The governing authorities in BOTH countries DO NOT investigate or arrest people without consumer complaints.
They DO NOT remove ticker symbols without consumer complaints.
I read that Raymond C. Dabney was supposed to be overseeing a family trust fund ... I wonder how that family feels abut him now. They in Canada n he's in the USA. How many times has he done this scam?
He's done it so much and is so self confident he puts his picture on CBIS company website. Or maybe that's his brother or son or who the FONG evah. Never any addresses for all those pharmacies he says they've opened. If there were really pharmacies opening he'd want business at them via CUSTOMERS ... he's NOT advertising for customers. No pictures of any of them. He's gonna continue to rip people off and I'm NOT gonna help him.
14 days ago I purchased a penny pot stock and it's UP 195.5% at opening bell today.
There are better, more reputable stocks to choose from.
I've learned a lot from the folks that post on Investors hub and I'm thankful for the help and I'd like to pay it forward as much as I can. I guess I'm just not fitting in much when I post my opinions.
Just so ya know ... I'm NOT a tel-evangelist fan. Most of them are scammers too. ESPECIALLY Jim Baker. God sends us all types of people to learn from and He sent ME ... YOU. I'm supposed to learn something from you and I believe I've got the lesson and I'm taking it with me as I move to better stocks to pic from.
GOD BLESS US EVERYONE !!!!
Raymond C. Dabney
Should be in prison! He's an international stock scam runner.
The law and rules mean NOTHING to him therefore he should be in prison for 25-30 years! He likes to separate people from their money, so he needs to be separated from his scam opportunities.
We ALL should notify the Canadian authorities AND the USA SEC and let them know he's a defiant repeat offender.
OTCmarkets 99.9% Scams .. DD please
https://www.otcmarkets.com/learn/otc-market-tiers
Lots of excellent tools to help investors, the 'LEARN' tab has more information.
They have a 'Stock Screener tool' under the 'Research' tab, they have current news and current press releases too for each company listed. They have charts, and financials for each company listed. It's NOT ALL 99.9% junk stocks.
Our Three Markets
Our financial markets provide investors with the information necessary to intelligently analyze, value and trade 10,000 U.S. and global securities through the broker of their choice.
To create clarity in the investment process, we organize these securities into three markets - OTCQX, OTCQB and Pink - based on the quality and quantity of information the companies make available.
OTCQX Market
The Best Market
The OTCQX® Best Market is for established investor-focused U.S. and global companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, and have a professional third-party sponsor introduction. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.
OTCQB Market
The Venture Market
The OTCQB® Venture Market is for entrepreneurial and development stage U.S. and international companies that are unable to qualify for OTCQX. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. These standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. Companies must meet a minimum $0.01 bid price test and may not be in bankruptcy.
Pink Market
The Open Market
The Pink® Open Market offers trading in a wide spectrum of equity securities through any broker. This market is for all types of companies that are there by reasons of default, distress or design, which is why they are further sub-categorized by the levels of information that they provide.
Current Information
Companies may be categorized in Current Information by following the International Reporting Standard, which requires the company to be listed on a Qualifying Foreign Exchange that requires periodic disclosure filings, or by following the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to the Pink Basic Disclosure Guidelines. The Current Information category is based on the level and timely availability of disclosure and is not a designation of quality or investment risk.
OTC Pink Limited Information Logo
Limited Information
Designed for companies with financial reporting problems, economic distress, or in bankruptcy to make the limited information they have publicly available. The Limited Information category also includes companies that may not be troubled, but are unwilling to provide disclosure pursuant to Pink Basic Disclosure Guidelines. Companies in this category have limited financial information not older than six months available on the OTC Disclosure & News Service or have made a required filing on the SEC's EDGAR system in the previous six months.
OTC Pink No Information Logo
No Information
Indicates companies that are not able or willing to provide disclosure to the public markets - either to a regulator, an exchange or OTC Markets Group. Companies in this category do not make Current Information available via OTC Markets Group's News Service, or if they do, the available information is older than six months. This category includes defunct companies that have ceased operations as well as 'dark' companies with questionable management and market disclosure practices. Publicly traded companies that are not willing to provide information to investors should be treated with suspicion and their securities should be considered highly risky.
Other Market Designations
Caveat Emptor Logo
Caveat Emptor
Buyer Beware. There is a public interest concern associated with the company, security, or control person which may include but is not limited to a spam campaign, questionable stock promotion, investigation of fraudulent or other criminal activity, regulatory suspensions, or disruptive corporate actions. During the time it is labeled Caveat Emptor, any stock that is not in Pink Current Information will also have its quotes blocked on www.otcmarkets.com.
Grey Market Logo
OTC, Other OTC or Grey Market
"OTC", "Other OTC" or "Grey Market" is a security that is not currently traded on the OTCQX, OTCQB or Pink markets. Broker-dealers are not willing or able to publicly quote OTC securities because of a lack of investor interest, company information availability or regulatory compliance.
Friday January 5, 2018
In a letter ...
signed by ...
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
Courts in Canada AND USA say no leadership position for five years.
I believe the judge/s need to SEE THIS letter.
That letter has been publicly broadcasted via GLOBEWIRE NEWS.
I believe he's narcissistic ... he believes the rules do not apply to him. He's an international swindler/con artist/scammer/scoundrel who should be behind bars for a very very very long time.
Robert C. Dabney - Forbes Article 2014
https://www.forbes.com/sites/nathanvardi/2014/03/10/the-first-pot-stock-billionaire-says-his-penny-stock-could-be-a-little-high/#415a2ba514bd
The Financial Industry Regulatory Authority warned investors back in August about marijuana stock scams, saying “the con artists behind marijuana stock scams may try to entice investors with optimistic and potentially false and misleading information that in turn creates unwarranted demand for shares of small, thinly traded companies that often have little or no history of financial success.” It’s not hard to figure out that some of the people behind the penny pot stock boom have questionable backgrounds.
Take Raymond Dabney. In 2005, the British Columbia Securities Commission up in Canada (he's working in the USA now out in California less than 5 years later) slapped a five-year trading ban on Dabney and barred him from being an officer or director of a publicly-traded company for five years after Dabney admitted to issuing 22 bogus news releases that contained misrepresentations about the revenue of Xraymedia, a Minnesota company in which Dabney was a controlling shareholder. The Securities & Exchange Commission also sued Dabney and in 2010 obtained a final judgment against him that included a disgorgement and penalty of about $190,000. The SEC launched the enforcement action against Dabney and three others in connection with a scheme to manipulate the price and trading volume of Alliance Transcription Services. Today, Dabney works as a management consultant for Cannabis Science, a cannabis formulation-based drug development company that trades on the OTCBB. Dabney is described in SEC filings as the trustee of the Bogat Family Trust, which owned 6.5% of Cannabis Science last year.
Bruce Perlowin, CEO of another Las Vegas-based OTCBB stock called Hemp Inc., is completely open about the nine years he spent in prison for drug smuggling, which he describes on his own web site. “This is a dot.com explosion except there is a real product behind us, not air,” Perlowin recently said in an interview he scored on Bloomberg Television. The Southern Investigative Reporting Foundation last fall exposed the background of Vincent Mehdizadeh, the founder of a marijuana stock called Medbox, which included arrests or no contest pleas for things like trespassing and credit card fraud.
A year ago, an anonymous poster on Seeking Alpha exposed that Michael Llamas, the former president of publicly-traded Medical Marijuana, had been indicted by federal prosecutors in California for his alleged involvement in a mortgage fraud that caused $10 million in losses. Llamas has pleaded not guilty to the federal charges and Medical Marijuana separately disclosed last year that it was being investigated by the SEC.
So there are some shady characters behind the penny pot stock boom. Mackay, who says he has in the past represented other companies with OTCBB stock listings, says CannaVest CEO Michael Mona, Jr., partially brought him aboard to help navigate the OTCBB underbelly. “I am familiar with a lot of the garbage that goes on with over the counter stocks, the pitfalls, and I guess that is one of the reasons why I decided to help Mike and help this process to avoid some of the pitfalls,” Mackay said.
Nevertheless, the indicted Llamas is connected to Mona, Mackay and CannaVest. Mackay’s path to obtaining most of his $1.8 billion of shares in CannaVest starts with Roen Ventures, a company that last year agreed to lend $6 million to CannaVest. Roen Ventures was formed by Mona and Llamas, according to a lawsuit filed against Mona and Mackay in Nevada state court. The lawsuit, filed in February by Far West Industries, claims that Far West obtained a $17.7 million judgment in 2012 against Mona and others relating to a fraudulent land transaction in California. According to the second amended complaint, Mona testified in the judgment debtor exam that he received $3 million that he loaned to Roen Ventures, which lent the money to CannaVest. Mona then testified that in the last year he sold his interest in Roen Ventures and its $3 million note to Mackay for $500,000—making Mackay and Llamas the owners of Roen Ventures, the second amended complaint says. Mona testified that there is another $22 million judgment pending against him connected to another real estate deal, the second amended complaint says. Far West claims in its second amended complaint that Mona’s loan to Roen Ventures was fraudulent and “intended to prejudice creditors like Far West by concealing and wasting assets.” Mackay declined to comment on the lawsuit, except to say that “from my perspective, it’s frivolous and doesn’t hold water.” Mona did not return a call seeking comment for this article.
In January of 2014, CannaVest said in an SEC filing that Roen Ventures is now wholly owned by Mackay, who acknowledged in an interview that he has bought out the stakes of Llamas and Mona in Roen Ventures. According to the January SEC filing, Mackay, through Mercia Holdings and Mai Dun Limited, now owns 100% of Roen Ventures, which has converted its loans to CannaVest to 10 million shares of CannaVest stock.
How did Mackey get the rest of his shares in CannaVest? In November of 2012, two of Mackay’s companies started acquiring shares of a publicly-traded OTCBB company called Foreclosure Solutions, mostly from H.J. Cole. The man behind the deal was Stuart Titus, who loaned the Mackay companies the money and whose General Hemp also participated, taking a 7.1% stake. Foreclosure Solutions became CannaVest and last week for some reason CannaVest moved to distance itself from Titus, saying in a press release that Titus no longer has any affiliation with CannaVest and owns less than 2% of the company.
There is another connection between CannaVest and Llamas. On the last day of 2012, CannaVest agreed to buy assets from something called PhytoSphere, including a license to use its brands, for $35 million in five payments of either cash or stock. When the deal closed last year, CannaVest issued 900,000 shares to PhytoSphere, which distributed the shares to its sole owners, Medical Marijuana and Hemp Deposit and Distribution Corporation, according to an SEC filing. Llamas used to be president of Medical Marijauna and its financial statements have previously describes Llamas as the president of Hemp Deposit and Distribution Corporation. Llamas’ LinkedIn page says he is the founder of Hemp Deposit’s CannaBank business. “To draw an inference that Mike Llamas has something to do with CannaVest is absolutely wrong,” says Mackay. “Llamas is not a member of the board and has absolutely no influence. I know Michael Llamas and am familiar with him but he has no control on any aspect of CannaVest. He may be a shareholder of CannaVest.”
CannaVest’s most up-to-date books show $10.7 million of assets. For the nine months ending September 30, 2013, the last time period for which CannaVest reported financials, revenues were $1.35 million and losses were $28.4 million. Mackay concedes these fundamentals don’t really support a sky-high stock valuation. “What you have here is in some ways, in my mind, is a perfect storm where for some reason marijuana stocks are getting some probably under normal reasonable terms outlandish valuations. I can’t control that because we don’t put out a lot of news, we are not out pumping stock,” says Mackay. “I am focusing on CannaVest and the fundamentals of this business as a member of a board of directors rather than pumping stock in a stock play.”
manny ... I did some research into the long term effects of smoking marijuana ... Medical Marijuana will be quite different I'm sure ... or maybe not. Time will tell.
https://vapingdaily.com/marijuana-side-effects/
I think after reading this and other articles Sessions concerns are the overwhelming burden on our healthcare system AND welfare AND disability which are all funded by our tax dollars.
I this this company is a GOOD COMPANY and I own stock in it.
I posted my comment to see how others feel about all this mess over marijuana. I should not have done that.
Before we talk about the side effects of marijuana, let’s get to know what this most commonly used illicit drug in America actually is and how it works.
Marijuana, weed, cannabis, hashish, bud, skunk, ganja, ‘erb and so many other names are used for the naturally occurring substance that has been used for hundreds of years as a relaxant or a mild hallucinogenic. Marijuana is actually a Spanish word and refers to the dried leaves, flowers, stems or seeds of a hemp plant known as Cannabis Sativa.
One of most active ingredients of marijuana is Delta-9-tetrahydrocannabinol, commonly referred to as THC, which has the potential for making humans high. When THC enters the blood, its mind-altering capabilities come into action pretty quickly. THC and some other compounds can affect the way your body works.
Marijuana is so popular that at least one in every three Americans has used it once, and as the stigma attached to it is declining because of the modern scientific researches, it’s popularity is at an all-time high. It’s being legalized for medical or even recreational use in some states. Most users feel relaxed and happy, and it has been reported to ease certain pains, eliminate nausea and is also considered to be helpful in stopping vomiting in advanced cases of cancer or AIDS. People suffering from serious illnesses who lose appetite are also reported to find weed helpful in improving and augmenting their appetite.
Although occasional use isn’t believed to be harmful, negative side effects of marijuana can impact your body as well as the mind, can slow down reflexes and impair decision-making capabilities. It’s so potent that it can be detected in urine up to seven days after casual use and up to 30 days after regular, heavy use.
Common Terms for Marijuana
Hemp: it’s just a plant like any other. The leaves, flowers, stem and seeds of Cannabis Sativa hemp plant are used as weed.
Cannabis: scientific term to describe hemp plant.
Marijuana or weed: slang for cannabis leaves and flowers
Hashish: it’s an extract of weed, usually pressed resin from marijuana. Just like any other extract, hashish is more potent than regular weed.
Negative Side Effects of Cannabis
Like any other drug (including alcohol), the side effects from marijuana vary from person to person. One person might feel stressed and even disoriented while other might feel relaxed and focused. In addition to your body, several other factors including type and amount of cannabis, your mood or the current state of mind, your circumstances, environment/settings, your diet, and many others, can also play a huge rule in determining the effects of weed you’ll experience.
The most common and obvious side effects of THC are bloodshot eyes and dry mouth. And that’s why you’ll see that most potheads carry some sort of eye washing product with them. Other commonly reported side effects include, but not limited to, pointless giggling, sloth-like reflexes, loss of inhibitions, an enhanced appreciation for things like colors, music etc. you wouldn’t pay much attention to normally.
Most types of cannabis are mild, however, strong cannabis (e.g. skunk or purple haze) or too much usage can have stronger effects such as hallucination while some people also report increased anxiety and paranoia. Although it doesn’t augment risk-taking behavior like alcohol does, weed does impair mental functions such as memory, attention, and performance, which makes driving or operating heavy machinery risky.
Health Risks of Cannabis
Marijuana-health-risks
While many believe marijuana to be extremely dangerous, it’s actually considerably less harmful than other substances in the same class such as barbiturates, amphetamines etc. In fact, occasional use of weed is hardly ever associated with any health issues. Even for serious users, science has yet to prove any solid evidence of major health problems for the users or the society. Especially in individuals who are otherwise healthy, the biggest real harm marijuana can do is impaired control of movements.
However, for people who have heart and circulation disorders, low blood pressure, diabetes, or schizophrenia, weed can pose significant threats. No matter how weed enters your body, it impacts pretty every major organ in your body in one way or another, though not always negatively. Smoking and vaporizing yield instantaneous high as THC is absorbed immediately by your body, and you can be under the influence for up to four hours. For those who eat pot-laced brownies or cookies, the effects appear after quite. Here are a few issues that weed is commonly believed to trigger or augment.
Dependence
The biggest health issue of weed is dependence. Regular heavy usage might make you dependent, however, it’s far less addictive than tobacco as well as alcohol. In fact, it’s reported that only 10% people who use weed become addicted to it.
Higher Chances of Cardiac Arrest
When smoked, marijuana can increase your heart rate up to two times from the normal rate. The increased heartbeat rate is often linked to increased chances of heart attack, and that’s why doctors recommend heart patients to stay away from any form of cannabis.
Lung Irritation
Modern scientific studies confirm that unlike tobacco cigarettes, smoking cannabis isn’t linked to higher chances of getting lung cancer. But it can cause a cough and chest colds, and extended heavy use is also associate with lung irritation.
Brain Issues
Some people believe they achieve better concentration and mental stability after smoking weed, but THC in cannabis can have both short-term and long-term effects on the human brain.
When THC is absorbed by the body into the bloodstream, all the chemicals are carried to brain in addition to other organs. When THC reaches the brain, it’s supposed to impact certain brain cell receptors that contain chemicals similar to THC itself. These THC-like chemicals control brain development and other functions.
As for short-term effects of weed on the brain, it over-activates the receptor cells and the person feels the “high” and gets into a relaxed mood. The person’s senses of seeing colors or listening and even sense of time are altered. Heavy use can reduce thinking capabilities and can even cause memory loss for the short term.
As for long-term effects, the overall brain development of heavy weed users is believed to be affected, especially if they started using weed in teenage. A study suggested that teenage marijuana smokers lost on average eight IQ points between ages 13 and 38, and most of them never fully recovered even after quitting weed. On the flip side, those who started smoking weed in adult age didn’t lose any IQ points.
Impact on Sexual Health and Reproduction
For men, frequent heavy use of marijuana can affect sexual health by lowering their testosterone levels and sperm count, which could result in reduced fertility. Likewise, pregnant women, as well as babies in their womb, can be affected by marijuana use. For instance, because of the high levels of carbon monoxide in the smoke, birth weight could be lower than normal of the children whose mother has been smoking weed during pregnancy.
Other Health Risks of Cannabis
Some other common physical effects of weed are short-term forgetfulness, depression, dizziness, increased appetite, and slowed down reflexes. Heavy users who have been using weed for long periods of time can experience withdrawal symptoms when they stop taking the drug.
Increasing Levels of THC
Marijuana has been in use for centuries, however, in the past few years, the THC levels in cannabis are believed to be going up. Cannabis used to contain a maximum of 4% THC, but now this has gone as high as 7%. The increased levels of THC worries many health professionals who believe that now it might become more addictive and more potent for producing mind-altering impacts. It’s very hard to know the exact level of THC or other chemicals in cannabis, so even if you’re buying from a regulated dispensary, it’s difficult to have an idea how much THC your body will absorb and thus knowing the exact effects can be difficult. But many health professionals claim that increasing levels of THC can increase the potential side effects of marijuana use.
Can we Minimize the Side Effects of Weed?
Is marijuana lethal? Maybe not. Is it very dangerous? Science has yet to figure out whether its cons outweigh its pros or not. Is it more dangerous than tobacco? No. According to American Lungs Association, marijuana has four times more tar than tobacco, but the largest study of its kind shows it’s not linked to lung cancer, even in a case of heavy, regular smokers.
But at the end of the day, there are some side effects of marijuana. Tar, as well as other carcinogens, are released when weed or tobacco undergo combustion. So, people use alternative methods such as eating or drinking weed with food. But these methods have their downsides; for instance, making pot-laced brownies or brewing tea that has weed, is a lengthy and complicated process.
This leaves us with the modern, high-tech method of vaporizing weed. In this method, a modern device called vaporizer is used to turn weed into vapors by bringing it into contact with a heating element. Since there is no combustion, there is no tar and many other compounds that make weed harmful. Studies show that e-cigarettes are at least 95% less harmful than tobacco, and the same goes for weed. The good thing is that new vaporizers are refining the technology to further minimize or eliminate the risks involved, and the prices are also coming down. But don’t forget that there are a couple of hassles, like setting up the device and clean up the process, attached to vaping weed, which can be off-putting for someone who is used to instantly rolling and smoking a joint.
Remember, knowing the potential weed side effects and how to minimize them can go a long way for a healthy living, no matter you use marijuana for medical purposes or just for medical reasons.
Friday, January 5, 2018 ... Someone PLEASE!
Tell me what this Fonged up mess is about? Truth or more lies?
Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government Contracts, Supported US Federal Governments Since 2009, Looks for New Federal Policy to Properly Regulate Industry for Patients
IRVINE, CA, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce its support for the U.S. Federal Government, and the Company intends to step in with its experts to assist the Federal Government. The Company is looking to establish new Federal marijuana policy and calls on Department of Justice (DOJ) to help establish a properly-regulated Federal Policy for all patients’ safe access to pharmaceutical and pharmacy dispensed cannabinoids for various critical ailments.
Cannabis Science has launched several initiatives to study the use of cannabinoid-based medicines. For one such initiative, initial results on using nanoparticle drones to target and successfully kill stage four lung cancer cells with radiosensitizers and cannabinoids have been published in the cancer research journal “Frontiers in Oncology”.
The article can be viewed at https://www.frontiersin.org/articles/10.3389/fonc.2017.00208/full
This publication of our work has clearly documented our success in a one of the leading Oncology publications as evidence of our cannabinoid research expertise. “Nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids,” addresses drug delivery, and highlights an innovative strategy to deliver cannabinoids directly to cancer cells with minimal toxicities or side effects that have so far hampered clinical translation efforts.
Equally important, Cannabis Science has the grit in the industry: it has been registered and received its initial Federal Commercial and Government Entity (CAGE) Code clearance back in 2009. Cannabis Science is one of the only companies in its industry with the ability to work directly with the US Federal Government. Cannabis Science clearly intends to use its relationships and vast expertise within its team from a number of Government Agencies, University Medical Research, Government Medical Research, Pharmaceutical Drug Development, Pharmacy Dispensing, and a number of other key points on this matter. Cannabis Science will promptly address the divergences with the Federal Government and the American people who are actually looking to treat their ailments using pharmaceutical and pharmacy dispensed cannabinoids across the Country.
“As a research-based company, CBIS’ focus is on pharmaceutical drug development and on creating medicines that can help patients in need,” stated Dr. Allen Herman, CBIS’ Chief Medical Officer. “We believe there are a number of indications that can be effectively treated with cannabinoid-based medicines and we expect our research, development, and clinical trial initiatives to demonstrate this.”
The U.S. Federal Government clearance clearly places Cannabis Science as one of THE Leading Publicly Traded Company in this industry looking to establish a Federal regulatory governing body to convene over the laws, regulations and compliance of the cannabis industry. Cannabis Science, Inc. has also conducted its business in this manner since the 2009 approval from the U.S. Federal Government as if these policies and procedures had been established at a Federal level. Cannabis Science, Inc. wants to work hand in hand with the establishment of federal laws and regulations, work within the federal laws and regulations that already exist and with the federal agencies charged with enforcing them.
Cannabis Science is registered in SAM with three North American Industry Classification System (NAICS) Codes:
541711 – Research and Development in Biotechnology
621511 – Medical Laboratories
624230 – Emergency and Other Relief Services
“Cannabis Science is currently exploring a number of Federal government contracts and grant opportunities, individually and with its collaborators, with institutions such as the National Institutes of Health (NIH), institutes within NIH, such as the National Institute on Drug Abuse (NIDA), and others. There is a certain level of clearance Cannabis Science has received from the Defense Logistics Agency’s CAGE Program Office at the U.S. Department of Defense for the Federal Commercial and Government Entity (CAGE) Code program that allows CBIS instant access to U.S. Federal Government contract procurement and that puts the Company directly in line to benefit from the cannabinoid-based medicines industry,” stated Mr. Dabney. “As for the U.S. Federal Government, we believe we have a significant role to play, as a private sector stakeholder, as well as a company that can support federally-funded contracts and grant opportunities as an experienced contractor. Our Team is honored to be a part of the process involved with the establishment of these Laws, Policies, Regulations and Compliance and possibly become a part of the business model for the private sector to adhere to.”
About Cannabis Science, Inc.
Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Contact Information
Cannabis Science, Inc.
Dr. Allen Herman
Chief Medical Officer
allen.herman@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
© 2018 GlobeNewswire, Inc.